{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Apellis Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"APLS"},"Address":{"label":"Address","value":"100 FIFTH AVENUE, WALTHAM, Massachusetts, 2451, United States"},"Phone":{"label":"Phone","value":"+1 617 977-5700"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade."},"CompanyUrl":{"label":"Company Url","value":"https://www.apellis.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Caroline Baumal","title":"Chief Medical Officer"},{"name":"Cedric Francois","title":"President, Chief Executive Officer &amp; Director"},{"name":"Nur Nicholson","title":"Chief Technical Operations Officer"},{"name":"Pascal Deschatelets","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}